Defunct Company
Total Trials
3
As Lead Sponsor
As Collaborator
0
Total Enrollment
132
NCT03144245
Study of AMV564 in Patients With AML
Phase: Phase 1
Role: Lead Sponsor
Start: Mar 20, 2017
Completion: Nov 5, 2020
NCT03516591
A Phase 1 Study of AMV564 in Patients With Intermediate or High-Risk Myelodysplastic Syndromes
Start: Jun 22, 2018
Completion: Jul 31, 2020
NCT04128423
Study of AMV564 in Subjects With Advanced Solid Tumors
Start: Oct 9, 2019
Completion: Dec 31, 2021